MANAGEMENT OF STAGE-T1 SUPERFICIAL BLADDER-CANCER WITH INTRAVESICAL BACILLUS CALMETTE-GUERIN THERAPY

被引:123
作者
COOKSON, MS [1 ]
SAROSDY, MF [1 ]
机构
[1] UNIV TEXAS,HLTH SCI CTR,DIV UROL,7703 FLOYD CURL DR,SAN ANTONIO,TX 78284
关键词
BLADDER NEOPLASMS; BCG VACCINE; CARCINOMA INSITU;
D O I
10.1016/S0022-5347(17)36724-1
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
We reviewed our results with 86 patients who had a pretreatment history of a stage T1 tumor. All patients were treated with transurethral resection of all visible tumor followed by intravesical bacillus Calmette-Guerin (BCG) and many patients received additional maintenance therapy. Local recurrences were treated with repeat transurethral resection followed by additional BCG. Median followup was 59 months, with a range of 9 to 149 months. Overall, 78 of 86 patients (91%) were free of tumor recurrence with BCG therapy. This result includes 69% of the patients who responded to the initial transurethral resection and intravesical BCG, and 22% who ceased having tumors after additional treatments for local recurrences. Only 7% of the patients had progression to stage T2 tumors after BCG therapy. Grade of the stage T1 tumor, concurrent carcinoma in situ and tumor multiplicity before BCG did not predict tumor recurrence or progression. Of patients with recurrences after BCG therapy, those with stage T1 tumors had a higher rate of progression compared to those with stage Ta tumors but the difference was not statistically significant (p = 0.086). These data clearly support the efficacy of transurethral resection plus intravesical BCG immunotherapy in the treatment of stage T1 tumors as well as in the prevention of disease progression.
引用
收藏
页码:797 / 801
页数:5
相关论文
共 24 条
  • [1] ADOLPHS HD, 1983, APR ANN M AM UR ASS, P178
  • [2] THE PT1-G3 BLADDER-TUMOR
    BIRCH, BRP
    HARLAND, SJ
    [J]. BRITISH JOURNAL OF UROLOGY, 1989, 64 (02): : 109 - 116
  • [3] EXPERIENCE WITH BACILLUS CALMETTE-GUERIN IN PATIENTS WITH SUPERFICIAL BLADDER-CARCINOMA
    BROSMAN, SA
    [J]. JOURNAL OF UROLOGY, 1982, 128 (01) : 27 - 30
  • [4] DALBO V, 1990, EUR UROL S1, V18, P43
  • [5] THE CORRELATION OF T1 BLADDER-TUMOR HISTORY WITH PROGNOSIS AND FOLLOW-UP REQUIREMENTS
    ENGLAND, HR
    PARIS, AMI
    BLANDY, JP
    [J]. BRITISH JOURNAL OF UROLOGY, 1981, 53 (06): : 593 - 597
  • [6] EURE G R, 1990, Journal of Urology, V143, p341A
  • [7] 2 COURSES OF INTRAVESICAL BACILLUS CALMETTE-GUERIN FOR TRANSITIONAL CELL-CARCINOMA OF THE BLADDER
    HAAFF, EO
    DRESNER, SM
    RATLIFF, TL
    CATALONA, WJ
    [J]. JOURNAL OF UROLOGY, 1986, 136 (04) : 820 - 824
  • [8] SUPERFICIAL BLADDER-CANCER - PROGRESSION AND RECURRENCE
    HENEY, NM
    AHMED, S
    FLANAGAN, MJ
    FRABLE, W
    CORDER, MP
    HAFERMANN, MD
    HAWKINS, IR
    [J]. JOURNAL OF UROLOGY, 1983, 130 (06) : 1083 - 1086
  • [9] Herr H W, 1990, Semin Urol, V8, P254
  • [10] BACILLUS CALMETTE-GUERIN THERAPY ALTERS THE PROGRESSION OF SUPERFICIAL BLADDER-CANCER
    HERR, HW
    LAUDONE, VP
    BADALAMENT, RA
    OETTGEN, HF
    SOGANI, PC
    FREEDMAN, BD
    MELAMED, MR
    WHITMORE, WF
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (09) : 1450 - 1455